Logo image of MS

MORGAN STANLEY (MS) Stock Fundamental Analysis

NYSE:MS - New York Stock Exchange, Inc. - US6174464486 - Common Stock - Currency: USD

109.18  +1.32 (+1.22%)

After market: 109.51 +0.33 (+0.3%)

Fundamental Rating

3

MS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 227 industry peers in the Capital Markets industry. MS has a bad profitability rating. Also its financial health evaluation is rather negative. MS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MS had positive earnings in the past year.
In the past year MS had a positive cash flow from operations.
MS had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MS reported negative operating cash flow in multiple years.
MS Yearly Net Income VS EBIT VS OCF VS FCFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B

1.2 Ratios

MS has a Return On Assets of 1.05%. This is in the lower half of the industry: MS underperforms 66.08% of its industry peers.
MS's Return On Equity of 12.25% is fine compared to the rest of the industry. MS outperforms 65.20% of its industry peers.
With a Return On Invested Capital value of 1.34%, MS is not doing good in the industry: 69.16% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for MS is significantly below the industry average of 7.06%.
The 3 year average ROIC (1.17%) for MS is below the current ROIC(1.34%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.05%
ROE 12.25%
ROIC 1.34%
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
MS Yearly ROA, ROE, ROICMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

MS's Profit Margin of 11.93% is in line compared to the rest of the industry. MS outperforms 42.73% of its industry peers.
In the last couple of years the Profit Margin of MS has declined.
MS has a worse Operating Margin (16.40%) than 63.44% of its industry peers.
MS's Operating Margin has declined in the last couple of years.
MS has a Gross Margin of 53.71%. This is in the better half of the industry: MS outperforms 63.00% of its industry peers.
In the last couple of years the Gross Margin of MS has declined.
Industry RankSector Rank
OM 16.4%
PM (TTM) 11.93%
GM 53.71%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
MS Yearly Profit, Operating, Gross MarginsMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

0

2. Health

2.1 Basic Checks

The number of shares outstanding for MS has been reduced compared to 1 year ago.
Compared to 5 years ago, MS has more shares outstanding
The debt/assets ratio for MS is higher compared to a year ago.
MS Yearly Shares OutstandingMS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MS Yearly Total Debt VS Total AssetsMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

Based on the Altman-Z score of -0.09, we must say that MS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MS (-0.09) is worse than 77.09% of its industry peers.
A Debt/Equity ratio of 6.99 is on the high side and indicates that MS has dependencies on debt financing.
MS has a worse Debt to Equity ratio (6.99) than 86.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.99
Debt/FCF N/A
Altman-Z -0.09
ROIC/WACCN/A
WACCN/A
MS Yearly LT Debt VS Equity VS FCFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

A Current Ratio of 0.30 indicates that MS may have some problems paying its short term obligations.
The Current ratio of MS (0.30) is worse than 80.18% of its industry peers.
A Quick Ratio of 0.30 indicates that MS may have some problems paying its short term obligations.
MS has a worse Quick ratio (0.30) than 80.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
MS Yearly Current Assets VS Current LiabilitesMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

5

3. Growth

3.1 Past

MS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 51.33%, which is quite impressive.
Measured over the past years, MS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.88% on average per year.
MS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.79%.
Measured over the past years, MS shows a quite strong growth in Revenue. The Revenue has been growing by 14.79% on average per year.
EPS 1Y (TTM)51.33%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%28.71%
Revenue 1Y (TTM)10.79%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%17.2%

3.2 Future

The Earnings Per Share is expected to grow by 6.26% on average over the next years.
The Revenue is expected to grow by 3.10% on average over the next years.
EPS Next Y12.75%
EPS Next 2Y11.49%
EPS Next 3Y11.06%
EPS Next 5Y6.26%
Revenue Next Year8.15%
Revenue Next 2Y6.93%
Revenue Next 3Y5.75%
Revenue Next 5Y3.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MS Yearly Revenue VS EstimatesMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
MS Yearly EPS VS EstimatesMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.81, MS is valued correctly.
MS's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.29. MS is valued rather cheaply when compared to this.
MS is valuated reasonably with a Price/Forward Earnings ratio of 11.06.
MS's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.08. MS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.81
Fwd PE 11.06
MS Price Earnings VS Forward Price EarningsMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MS is cheaper than 77.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.73
MS Per share dataMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.01
PEG (5Y)1.44
EPS Next 2Y11.49%
EPS Next 3Y11.06%

6

5. Dividend

5.1 Amount

MS has a Yearly Dividend Yield of 3.43%.
In the last 3 months the price of MS has falen by -20.81%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
MS's Dividend Yield is comparable with the industry average which is at 8.84.
MS's Dividend Yield is a higher than the S&P500 average which is at 2.57.
Industry RankSector Rank
Dividend Yield 3.43%

5.2 History

On average, the dividend of MS grows each year by 18.94%, which is quite nice.
MS has paid a dividend for at least 10 years, which is a reliable track record.
MS has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)18.94%
Div Incr Years10
Div Non Decr Years13
MS Yearly Dividends per shareMS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MS pays out 47.95% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of MS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP47.95%
EPS Next 2Y11.49%
EPS Next 3Y11.06%
MS Yearly Income VS Free CF VS DividendMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B
MS Dividend Payout.MS Dividend Payout, showing the Payout Ratio.MS Dividend Payout.PayoutRetained Earnings

MORGAN STANLEY

NYSE:MS (4/17/2025, 8:04:00 PM)

After market: 109.51 +0.33 (+0.3%)

109.18

+1.32 (+1.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-11 2025-04-11/bmo
Earnings (Next)07-16 2025-07-16/bmo
Inst Owners62.19%
Inst Owner Change0.01%
Ins Owners0.19%
Ins Owner Change0%
Market Cap175.62B
Analysts72.9
Price Target141.21 (29.34%)
Short Float %1.16%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 3.43%
Yearly Dividend3.8
Dividend Growth(5Y)18.94%
DP47.95%
Div Incr Years10
Div Non Decr Years13
Ex-Date01-31 2025-01-31 (0.925)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.16%
Min EPS beat(2)15.26%
Max EPS beat(2)27.07%
EPS beat(4)4
Avg EPS beat(4)16.98%
Min EPS beat(4)7.49%
Max EPS beat(4)27.07%
EPS beat(8)7
Avg EPS beat(8)9.28%
EPS beat(12)9
Avg EPS beat(12)6.46%
EPS beat(16)13
Avg EPS beat(16)7.97%
Revenue beat(2)2
Avg Revenue beat(2)4.23%
Min Revenue beat(2)3.68%
Max Revenue beat(2)4.78%
Revenue beat(4)4
Avg Revenue beat(4)3.09%
Min Revenue beat(4)1.95%
Max Revenue beat(4)4.78%
Revenue beat(8)5
Avg Revenue beat(8)8.56%
Revenue beat(12)9
Avg Revenue beat(12)12.37%
Revenue beat(16)12
Avg Revenue beat(16)10.47%
PT rev (1m)-0.92%
PT rev (3m)9.58%
EPS NQ rev (1m)-4.14%
EPS NQ rev (3m)3.14%
EPS NY rev (1m)0.75%
EPS NY rev (3m)9.19%
Revenue NQ rev (1m)-1.78%
Revenue NQ rev (3m)3.44%
Revenue NY rev (1m)-1.68%
Revenue NY rev (3m)2.28%
Valuation
Industry RankSector Rank
PE 12.81
Fwd PE 11.06
P/S 1.64
P/FCF N/A
P/OCF 128.94
P/B 1.68
P/tB 2.16
EV/EBITDA 16.73
EPS(TTM)8.52
EY7.8%
EPS(NY)9.87
Fwd EY9.04%
FCF(TTM)-1.31
FCFYN/A
OCF(TTM)0.85
OCFY0.78%
SpS66.7
BVpS64.97
TBVpS50.58
PEG (NY)1.01
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 12.25%
ROCE 3.05%
ROIC 1.34%
ROICexc 1.5%
ROICexgc 1.58%
OM 16.4%
PM (TTM) 11.93%
GM 53.71%
FCFM N/A
ROA(3y)0.89%
ROA(5y)0.97%
ROE(3y)10.46%
ROE(5y)11.1%
ROIC(3y)1.17%
ROIC(5y)1.28%
ROICexc(3y)1.31%
ROICexc(5y)1.45%
ROICexgc(3y)1.39%
ROICexgc(5y)1.52%
ROCE(3y)2.71%
ROCE(5y)2.94%
ROICexcg growth 3Y-6.85%
ROICexcg growth 5Y1.53%
ROICexc growth 3Y-6.8%
ROICexc growth 5Y1.26%
OM growth 3Y-20.12%
OM growth 5Y-4.82%
PM growth 3Y-20.6%
PM growth 5Y-5.48%
GM growth 3Y-16.51%
GM growth 5Y-5.78%
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 6.99
Debt/FCF N/A
Debt/EBITDA 32.08
Cap/Depr 67.08%
Cap/Sales 3.23%
Interest Coverage 0.38
Cash Conversion 5.98%
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z -0.09
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)74.75%
Cap/Depr(5y)63.46%
Cap/Sales(3y)3.81%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.33%
EPS 3Y-0.38%
EPS 5Y8.88%
EPS Q2Q%28.71%
EPS Next Y12.75%
EPS Next 2Y11.49%
EPS Next 3Y11.06%
EPS Next 5Y6.26%
Revenue 1Y (TTM)10.79%
Revenue growth 3Y20.63%
Revenue growth 5Y14.79%
Sales Q2Q%17.2%
Revenue Next Year8.15%
Revenue Next 2Y6.93%
Revenue Next 3Y5.75%
Revenue Next 5Y3.1%
EBIT growth 1Y41.98%
EBIT growth 3Y-3.64%
EBIT growth 5Y9.26%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.06%
OCF growth 3Y-65.77%
OCF growth 5Y-49.33%